Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
Paul Joseph HampelTimothy G CallWei DingEli MuchtarSaad Sirop KenderianYucai WangJose F LeisThomas E WitzigAmber B KoehlerAmie L FonderSusan M SchwagerKari G RabeDaniel L Van DykeEsteban BraggioSusan L SlagerNeil E KaySameer A ParikhPublished in: American journal of hematology (2019)